CINDY HORRELL: Open Payments
NPI 1821088907 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 18 payments from 11 companies in 2025. Trend: 2023 $445 · 2024 $620 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| ABBVIE INC. | 3 | $101 |
| Daiichi Sankyo Inc. | 2 | $96 |
| TAIHO ONCOLOGY, INC. | 2 | $83 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| E.R. Squibb & Sons, L.L.C. | 1 | $69 |
| Astellas Pharma US Inc | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
Products named: LONSURF, DATROWAY, EPKINLY, OPDIVO, Vyloy, VENCLEXTA, PLUVICTO, KISQALI.
Industry payments across FL — which companies pay providers there.
